These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 6229873)

  • 1. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
    Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unaltered immunocompetence in patients with non-disseminated breast cancer at the time of diagnosis.
    Ludwig CU; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
    Cancer; 1985 Apr; 55(8):1673-8. PubMed ID: 3872158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of B and T lymphocyte surface markers in breast cancer patients using anti-B and anti-T cell monoclonal antibodies.
    Nowak JS; Lanzrein C
    Neoplasma; 1984; 31(3):281-9. PubMed ID: 6610835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal values of peripheral lymphocyte populations and T cell subsets at a fixed time of day: a flow cytometric analysis with monoclonal antibodies in 210 healthy adults.
    Ohta Y; Fujiwara K; Nishi T; Oka H
    Clin Exp Immunol; 1986 Apr; 64(1):146-9. PubMed ID: 2942319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer.
    Morton BA; Ramey WG; Paderon H; Miller RE
    Cancer Res; 1986 Apr; 46(4 Pt 2):2121-6. PubMed ID: 3081262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patients.
    Mantovani G; Serri FG; Macciò A; Castelli P; Benedetti P; Scambia G; Santus S; Paderi R; Murtas MG; Ferreli A
    Cancer Detect Prev; 1989; 13(5-6):323-32. PubMed ID: 2743354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Subset analysis of tumor infiltrating lymphocytes and peripheral blood lymphocytes in malignant glioma patients].
    Matsuhisa T
    No To Shinkei; 1995 May; 47(5):466-73. PubMed ID: 7786623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helper and suppressor T lymphocyte function in severe alcoholic liver disease.
    McKeever U; O'Mahony C; Whelan CA; Weir DG; Feighery C
    Clin Exp Immunol; 1985 Apr; 60(1):39-48. PubMed ID: 3159525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cellular immunity in breast cancer patients].
    Spielmann M; Kitschke HJ; Tietje K
    Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficient concanavalin-A-induced suppressor cell activity in women with untreated breast cancer.
    Gupta S; Cunningham-Rundles S
    J Clin Lab Immunol; 1982 Dec; 9(3):159-61. PubMed ID: 6220154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of immunoregulatory T lymphocytes during ageing by monoclonal antibodies.
    Mascart-Lemone F; Delespesse G; Servais G; Kunstler M
    Clin Exp Immunol; 1982 Apr; 48(1):148-54. PubMed ID: 6211314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane phenotype and functional behaviour of T lymphocytes in multiple myeloma: correlation with clinical stages of the disease.
    Lauria F; Foa R; Cavo M; Gobbi M; Raspadori D; Giubellino MC; Tazzari PL; Tura S
    Clin Exp Immunol; 1984 Jun; 56(3):653-8. PubMed ID: 6235070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte profiles in patients with chronic low back pain enrolled in a clinical trial.
    Brennan PC; Graham MA; Triano JJ; Hondras MA; Anderson RJ
    J Manipulative Physiol Ther; 1994 May; 17(4):219-27. PubMed ID: 8046277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunophenotyping of lymphocyte subpopulations using monoclonal antibodies in an analytical flow cytometer: evaluation of the method and reference values].
    Neumeier D; Pauls R; Wifling I; Fateh-Moghadam A; Knedel M
    J Clin Chem Clin Biochem; 1985 Nov; 23(11):765-75. PubMed ID: 4086981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
    Auer IO; Röder A; Fröhlich J
    Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Two-color analysis of lymphocyte subpopulations in membranous nephropathy and minimal change nephrotic syndrome].
    Ozaki T
    Nihon Jinzo Gakkai Shi; 1989 Aug; 31(8):797-806. PubMed ID: 2593316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical evaluation of lymphocyte functions in urological cancer patients.
    Elhilali MM; Paika KD; Brosman S; Fahey JL
    Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
    Karavodin LM; Golub SH
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):193-202. PubMed ID: 6241293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A serial study of peripheral blood T lymphocyte subsets in relapsing-remitting multiple sclerosis.
    Kastrukoff LF; Paty DW
    Ann Neurol; 1984 Mar; 15(3):250-6. PubMed ID: 6232891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.